Evidence map›Paper›PMID 37923944›Full record

ArticleArchives of microbiology2023

Virulence genotype and phenotype of two clinical isolates of Arcobacter butzleri obtained from patients with different pathologies.

Itsaso Baztarrika, Adrián Salazar-Sánchez, Silvia Hernaez Crespo, José Israel López Mirones, Andrés Canut, Rodrigo Alonso, Ilargi Martínez-Ballesteros, Irati Martinez-Malaxetxebarria

Open access · hybridAbstract read
In one paragraph

Article in Archives of microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. First reported case ofIDCases · 2026
    Article
  3. Observational
  4. Article
  5. Antibiotics (Basel, Switzerland) · 2024
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Itsaso BaztarrikaMikroIker Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-d Gasteiz, Spain.ORCID http://orcid.org/0000-0002-7912-5417
Adrián Salazar-SánchezMikroIker Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-d Gasteiz, Spain.ORCID http://orcid.org/0000-0002-2454-4753
Silvia Hernaez CrespoBioaraba, Microbiology, Infectious Diseases, Antimicrobial Agents and Gene Therapy, 01006, Vitoria-Gasteiz, Spain.
José Israel López MironesBioaraba, Microbiology, Infectious Diseases, Antimicrobial Agents and Gene Therapy, 01006, Vitoria-Gasteiz, Spain.
Andrés CanutBioaraba, Microbiology, Infectious Diseases, Antimicrobial Agents and Gene Therapy, 01006, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0003-3836-9906
Rodrigo AlonsoMikroIker Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-d Gasteiz, Spain.ORCID http://orcid.org/0000-0002-8129-4850
Ilargi Martínez-BallesterosMikroIker Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-d Gasteiz, Spain.ORCID http://orcid.org/0000-0002-8867-1487
Irati Martinez-MalaxetxebarriaMikroIker Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-d Gasteiz, Spain. irati.martinez@ehu.eus.ORCID http://orcid.org/0000-0002-6576-6707
University of the Basque Country · ES

Funding

Euskal Herriko Unibertsitatea GIU21/021Eusko Jaurlaritza PA20/03
6 · The paper itself

Abstract

The surge in human arcobacteriosis has increased interest in determining the mechanisms involved in the pathogenesis of Arcobacter butzleri. Here, genomic analyses and in vitro Caco-2 infection, motility, urease and antimicrobial susceptibility testing (AST) assays were used to characterise the virulence and antimicrobial resistance (AMR) determinants of strains HC-1, isolated from a patient with travellers' diarrhoea, and HC-2, isolated from another with pruritus. AMR determinants conferring resistance to tetracycline (tetO, present in both genomes) and to ampicillin and amoxicillin-clavulanic acid (bla3, present in HC-2) were identified. The same determinants associated with flagellum, chemotaxis, adhesion and invasion were detected in both, but HC-1 lacked eight flagellar genes. The urease cluster was only present in HC-1. Motility and urease tests confirmed the genetic differences between strains, but no genetic marker related to the inability of HC-2 to adhere and invade was identified. This inability could be conditioning the patient's pathology.

Indexed as

ArcobacterAnti-Bacterial AgentsCaco-2 CellsGenotypeHumansPhenotypeUreaseVirulenceAnti-Bacterial AgentsUreaseAntimicrobial resistanceArcobacter butzleriCaco-2 infectionComparative genomicsVirulence

Identifiers

PMID37923944
PMCPMC10624747
OpenAlexW4388346358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.